Determinants of high cardiovascular risk in relation to plaque-composition of a non-culprit coronary segment visualized by near-infrared spectroscopy in patients undergoing percutaneous coronary intervention

European Heart Journal

Volumn 35, Issue 5, 2014, Pages

  De Boer, Sanneke P M ^a   Brugaletta, Salvatore ^a   Garcia Garcia, Hector M ^a   Simsek, Cihan ^a   Heo, Jung Ho ^a   Lenzen, Mattie J ^a   Schultz, Carl ^a   Regar, Evelyn ^a   Zijlstra, Felix ^a   Boersma, Eric ^a   Serruys, Patrick W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cardiovascular risk factors; Lipid core burden index; Near infrared spectroscopy; Percutaneous coronary intervention

Indexed keywords

CARDIOVASCULAR RISK FACTORS; LIPID CORE BURDEN INDEX; NEAR-INFRARED SPECTROSCOPY; PERCUTANEOUS CORONARY INTERVENTION;

ACUTE CORONARY SYNDROME; ANGINA PECTORIS; C-REACTIVE PROTEIN; CORONARY ARTERY DISEASE; CORONARY VESSELS; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; LIPIDS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PLAQUE, ATHEROSCLEROTIC; RISK FACTORS; SPECTROSCOPY, NEAR-INFRARED;

EID: 84893825222     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/eht378     Document Type: Article

References (36)

1. Writing Group M, Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Thom T, Wasserthiel-Smoller S,Wong ND, Wylie-Rosett J, American Heart Association Statistics C, Stroke Statistics S. Heart disease and stroke statistics-2010 update: A report from the American Heart Association. Circulation 2010;121:e46-e215.
2. European Commission. Health statistics: Atlas on mortality in the European Union. 2009; http://epp.eurostat.ec.europa.eu/cache/ITY-OFFPUB/KS-30- 08- 357/EN/KS-30-08-357-EN.PDF (10 September 2013).
3. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, Fayad Z, Stone PH, Waxman S, Raggi P, Madjid M, Zarrabi A, Burke A, Yuan C, Fitzgerald PJ, Siscovick DS, de Korte CL, Aikawa M, Juhani Airaksinen KE, Assmann G, Becker CR, Chesebro JH, Farb A, Galis ZS, Jackson C, Jang IK, Koenig W, Lodder RA, March K, Demirovic J, Navab M, Priori SG, Rekhter MD, Bahr R, Grundy SM, Mehran R, Colombo A, Boerwinkle E, Ballantyne C, Insull W Jr, Schwartz RS, Vogel R, Serruys PW, Hansson GK, Faxon DP, Kaul S, Drexler H, Greenland P, Muller JE, Virmani R, Ridker PM, Zipes DP, Shah PK, Willerson JT. From vulnerable plaque to vulnerable patient: A call for new definitions and risk assessment strategies: Part I. Circulation 2003;108:1664-1672.
4. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, Fayad Z, Stone PH, Waxman S, Raggi P, Madjid M, Zarrabi A, Burke A, Yuan C, Fitzgerald PJ, Siscovick DS, de Korte CL, Aikawa M, Airaksinen KE, Assmann G, Becker CR, Chesebro JH, Farb A, Galis ZS, Jackson C, Jang IK, Koenig W, Lodder RA, March K, Demirovic J, Navab M, Priori SG, Rekhter MD, Bahr R, Grundy SM, Mehran R, Colombo A, Boerwinkle E, Ballantyne C, Insull W Jr, Schwartz RS, Vogel R, Serruys PW, Hansson GK, Faxon DP, Kaul S, Drexler H, Greenland P, Muller JE, Virmani R, Ridker PM, Zipes DP, Shah PK, Willerson JT. From vulnerable plaque to vulnerable patient: A call for new definitions and risk assessment strategies: Part II. Circulation 2003;108: 1772-1778.
5. Ross R. Atherosclerosis: An inflammatory disease. N Engl J Med 1999;340:115-126.
6. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. J Am Coll Cardiol 2006;47:C13-C18.
7. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: A comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000;20:1262-1275.
8. Helfand M, Buckley DI, Freeman M, Fu R, Rogers K, Fleming C, Humphrey LL. Emerging risk factors for coronary heart disease: A summary of systematic reviews conducted for the U.S. preventive services task force. Ann Intern Med 2009;151: 496-507.
9. Wilson PW. Established risk factors and coronary artery disease: The framingham study. Am J Hypertens 1994;7:7S-12S
10. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, Investigators IS. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the interheart study): Case-control study. Lancet 2004;364:937-952.
11. Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997;336:1276-1282.
12. Castelli WP, Anderson K, Wilson PW, Levy D. Lipids and risk of coronary heart disease. The Framingham Study. Ann Epidemiol 1992;2:23-28.
13. McQueen MJ, Hawken S,Wang X, Ounpuu S, Sniderman A, Probstfield J, Steyn K, Sanderson JE, Hasani M, Volkova E, Kazmi K, Yusuf S, investigators is. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the interheart study): A case-control study. Lancet 2008;372:224-233.
14. Cholesterol Treatment Trialists C, Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, Peto R, Barnes EH, Keech A, Simes J, Collins R. Efficacy and safety of more intensive lowering of ldl cholesterol: A meta-Analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010;376:1670-1681.
15. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97: 1837-1847.
16. National Cholesterol Education Program Expert Panel onDetection E, Treatment of High Blood Cholesterol in A. Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 2002; 106:3143-3421.
17. Buckley DI, Fu R, Freeman M, Rogers K, Helfand M. C-reactive protein as a risk factor for coronary heart disease: A systematic review and meta-Analyses for the U.S. preventive services task force. Ann Intern Med 2009;151:483-495.
18. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, KoenigW, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ, Group JS. Rosuvastatin to prevent vascular events in men and women with elevated c-reactive protein. N Engl J Med. 2008;359:2195-2207.
19. Gardner CM, Tan H, Hull EL, Lisauskas JB, Sum ST, Meese TM, Jiang C, Madden SP, Caplan JD, Burke AP, Virmani R, Goldstein J, Muller JE. Detection of lipid core coronary plaques in autopsy specimens with a novel catheter-based near-infrared spectroscopy system. JACC Cardiovasc Imaging 2008;1:638-648.
20. Waxman S, Dixon SR, L'Allier P, Moses JW, Petersen JL, Cutlip D, Tardif JC, Nesto RW, Muller JE, Hendricks MJ, Sum ST, Gardner CM, Goldstein JA, Stone GW, Krucoff MW. In vivo validation of a catheter-based near-infrared spectroscopy system for detection of lipid core coronary plaques: Initial results of the Spectacle Study. JACC Cardiovasc Imaging 2009;2:858-868.
21. Simsek C, Garcia-Garcia HM, Brugaletta S, de Boer SP, Magro M, Duckers HJ, van Geuns RJ, Boersma E, Serruys PW. Correlation between kidney function and nearinfrared spectroscopy derived lipid-core burden index score of a non-intervened coronary artery segment. Int J Cardiol 2012;156:226-228.
22. Heo JH, Garcia-Garcia HM, Brugaletta S, de Boer S, Simsek C, Farooq V, Boersma E, SerruysPW. Lipid core burden index and framingham score: Can a systemic risk score predict lipid core burden in non-culprit coronary artery? Int J Cardiol 2012;156: 211-213.
23. Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, Wood AM, Carpenter JR. Multiple imputation for missing data in epidemiological and clinical research: Potential and pitfalls. BMJ 2009;338:b2393.
24. CockcroftDW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
25. Kojima S, Kojima S, Maruyoshi H, Nagayoshi Y, Kaikita K, Sumida H, Sugiyama S, Funahashi T, Ogawa H. Hypercholesterolemia and hypoadiponectinemia are associated with necrotic core-rich coronary plaque. Int J Cardiol 2011;147:371-376.
26. Caixeta AM, Weisz G, Maehara A, Mintz GS, Cristea E, Mehran R, Fahy M, Xu K, Lansky AJ, McPherson J, De Bruyne B, Serruys PW, Stone GW. Impact of hypercholesterolemia on atherosclerotic plaque composition: A virtual histology intravascular ultrasound analysis from prospect. J Am Coll Cardiol 2011;57: E1678-E1678.
27. Han SH, Bae JH, Holmes DR Jr, Lennon RJ, Eeckhout E, Barsness GW, Rihal CS, Lerman A. Sex differences in atheroma burden and endothelial function in patients with early coronary atherosclerosis. Eur Heart J 2008;29:1359-1369.
28. Shaw LJ, Shaw RE, Merz CN, Brindis RG, Klein LW, Nallamothu B, Douglas PS, Krone RJ, McKay CR, Block PC, Hewitt K,Weintraub WS, Peterson ED, American College of Cardiology-National Cardiovascular Data Registry I. Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American college of cardiology-national cardiovascular data registry. Circulation 2008;117:1787-1801.
29. Shaw LJ, Bugiardini R, Merz CN.Women and ischemic heart disease: Evolving knowledge. J Am Coll Cardiol 2009;54:1561-1575.
30. Handberg E, Johnson BD, Arant CB, Wessel TR, Kerensky RA, von Mering G, Olson MB, Reis SE, Shaw L, Bairey Merz CN, Sharaf BL, Sopko G, Pepine CJ. Impaired coronary vascular reactivity and functional capacity in women: Results from the NHLBI women's ischemia syndrome evaluation (wise) study. J Am Coll Cardiol 2006;47:S44-S49.
31. Khuddus MA, Pepine CJ, Handberg EM, Bairey Merz CN, Sopko G, Bavry AA, Denardo SJ, McGorray SP, Smith KM, Sharaf BL, Nicholls SJ, Nissen SE, Anderson RD. An intravascular ultrasound analysis in women experiencing chest pain in the absence of obstructive coronary artery disease: A substudy from the national heart, lung and blood institute-sponsored women's ischemia syndrome evaluation (wise). J Intervent Cardiol 2010;23:511-519.
32. von Birgelen C, Hartmann M, Mintz GS, Baumgart D, Schmermund A, Erbel R. Relation between progression and regression of atherosclerotic left main coronary artery disease and serum cholesterol levels as assessed with serial long-term (. or 12 months) follow-up intravascular ultrasound. Circulation 2003;108: 2757-2762.
33. Nicholls SJ, Tuzcu EM, Crowe T, Sipahi I, Schoenhagen P, Kapadia S, Hazen SL, Wun CC, Norton M, Ntanios F, Nissen SE. Relationship between cardiovascular risk factors and atherosclerotic disease burden measured by intravascular ultrasound. J Am Coll Cardiol 2006;47:1967-1975.
34. Libby P. Atherosclerosis: Disease biology affecting the coronary vasculature. Am J Cardiol 2006;98:3Q-9Q
35. Madder RDSmith JL, Dixon SR, Goldstein JA. Composition of target lesions by nearinfrared spectroscopy in patients with acute coronary syndrome versus stable angina. Circ Cardiovasc Interv 2012;5:55-61.
36. Goldstein JA, Maini B, Dixon SR, Brilakis ES, Grines CL, Rizik DG, Powers ER, Steinberg DH, Shunk KA, Weisz G, Moreno PR, Kini A, Sharma SK, Hendricks MJ, Sum ST, Madden SP, Muller JE, Stone GW, Kern MJ. Detection of lipid-core plaques by intracoronary near-infrared spectroscopy identifies high risk of periprocedural myocardial infarction. Circ Cardiovasc Interv 2011;4:429-437.